Milestone Pharmaceuticals Inc (MIST)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.9000 -0.0500 (-2.56%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.9101 +0.0101 (+0.53%) 19:59 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 1,000 | 5,000 | 15,000 | 0 |
| Gross Profit | N/A | 1,000 | 5,000 | 15,000 | N/A |
| Operating Expenses | 42,102 | 62,098 | 64,642 | 58,073 | 50,710 |
| Operating Income | -42,102 | -61,098 | -59,642 | -43,073 | -50,710 |
| Interest Expense | 3,581 | 2,554 | 0 | 0 | 0 |
| Other Income | 4,164 | 3,967 | 1,254 | 220 | 726 |
| Pre-tax Income | -41,519 | -59,685 | -58,388 | -42,853 | -49,984 |
| Income Tax | N/A | N/A | N/A | N/A | -17 |
| Net Income Continuous | -41,519 | -59,685 | -58,388 | -42,853 | -49,967 |
| Net Income | $-41,519 | $-59,685 | $-58,388 | $-42,853 | $-49,967 |
| EPS Basic Total Ops | -0.67 | -1.39 | -1.38 | -1.02 | -1.70 |
| EPS Basic Continuous Ops | -0.67 | -1.39 | -1.38 | -1.02 | -1.70 |
| EPS Diluted Total Ops | -0.67 | -1.39 | -1.38 | -1.02 | -1.70 |
| EPS Diluted Continuous Ops | -0.67 | -1.39 | -1.38 | -1.02 | -1.70 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.39 | -1.38 | -1.02 | -1.70 |
| EBITDA(a) | $-41,997 | $-61,006 | $-59,553 | $-42,980 | $-50,613 |